We want to know if a new drug called Diamyd® will help your body keep its ability to make insulin by stopping your immune system from attacking the cells that make insulin. To do this, we will compare the effects of three injections of Diamyd® compared to a placebo drug. A placebo is an inactive substance that looks the same and is given the same way as Diamyd®. You/your child will be randomly assigned to get either Diamyd® or placebo, like flipping a coin. If you join this study, you will come to 11 visits over 2.5 years at the Barbara Davis Center on the CU Anschutz campus. At these visits we will ask about your health and do physical exams. We will measure your height, weight, and vital signs. We will also take a small blood sample from your arm with a needle, and we will ask you to give urine samples. We will ask you to wear a continuous glucose monitor at different times throughout the study. If you/your child completes all parts of the study, you will be paid up to $2,185.

Who can Participate

You/your child can join this study if you are between 12 and 29 years old and were diagnosed with type 1 diabetes within the past 6 months ago. If you are interested in joining this study, our team will do other tests to make sure you meet all eligibility criteria and that it is safe for you to join the study.

Study ID